Allergic Asthma
📧 Sign up to get email alerts when something new happens for Allergic Asthma.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2021-04-09FDA Approved: XOLAIR — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for XOLAIR (omalizumab) filed by Genentech to modify the labeling.